Partial Reinforcement II

Summary

Partial Reinforcement II is a clinical trial^[1].

Key Facts

• Partial Reinforcement II is in the country of United States^[2].
• Partial Reinforcement II's instance of is recorded as clinical trial^[3].
• Partial Reinforcement II's start time is recorded as +2019-04-15T00:00:00Z^[4].
• Partial Reinforcement II's end time is recorded as +2022-06-30T00:00:00Z^[5].
• Partial Reinforcement II's sponsor is recorded as University of Pennsylvania^[6].
• Partial Reinforcement II's number of participants is recorded as {'unit': '1', 'amount': '+200'}^[7].
• Partial Reinforcement II's title is recorded as Three Approaches to Maintenance Therapy for Chronic Insomnia in Older Adults^[8].
• Partial Reinforcement II's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+40'}^[9].
• Partial Reinforcement II's ClinicalTrials.gov ID is recorded as NCT03774810^[10].
• Partial Reinforcement II's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+85'}^[11].
• Partial Reinforcement II's research intervention is recorded as zolpidem^[12].
• Partial Reinforcement II's clinical trial phase is recorded as phase IV clinical trial^[13].
• Partial Reinforcement II's research site is recorded as University of Pennsylvania^[14].
• Partial Reinforcement II's research subject recruitment status is recorded as recruiting^[15].
• Partial Reinforcement II's study type is recorded as interventional study^[16].